共 25 条
[1]
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over 6 months. Drachman DE,Edelmam ER,Seifert P,et al. Journal of the American College of Cardiology . 2000
[2]
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Gallo R,Padurean A,Jayaraman T,et al. Circulation . 1999
[3]
Drug-eluting stents for the prevention of restenosis: in quest for the holy grail. Hiatt BL,Ikeno F,Yeung AC,et al. Catheterization and Cardiovascular Interventions . 2002
[4]
Fant J, Horwitz SB.Promotion of microtubuleassembly in vitro by taxol. Schiff PB. Nature . 1979
[5]
Sirolimus-eluting stent for treatment of in-stent restenosis: the first European clinical experience. Degertekin M,Regar E,Smits PC,et al. European Heart Journal . 2002
[6]
Can sirolimus-eluting stents prevent restenosis in diabetic patients? A subanalysis of the randomized, multi-center RAVEL trial. Regar E,Morice M,Sousa J,et al. European Heart Journal . 2002
[7]
First clinical experience with a paclitaxel derivate - eluting polymer stent system implantation for in - stent restenosis: immediate and long -term clinical and angiographic outcome. Liistro F,Stankovic G,Mario CD,et al. Circulation . 2002
[8]
Transplantation[P]. 英国专利:GB9904281D0,1999-04-21
[9]
Stent based sirolimus delivery reduces neointimal proliferation in a porcine coronary model of restenosis. Carter A J,Kopia G,Llanos G,et al. Journal of the American College of Cardiology . 2000
[10]
Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Axel DI,Kunert W,Goggelmann C,et al. Circulation . 1997